Market Closed -
Bombay S.E.
06:00:55 2024-04-26 am EDT
|
5-day change
|
1st Jan Change
|
398.9
INR
|
+0.82%
|
|
+5.36%
|
-7.63%
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
890.8
|
769.2
|
705.4
|
933.8
|
1,252
|
1,767
|
Enterprise Value (EV)
1 |
759.3
|
548.5
|
595.8
|
812
|
1,053
|
1,657
|
P/E ratio
|
11.1
x
|
7.64
x
|
5.48
x
|
11
x
|
10.1
x
|
11.6
x
|
Yield
|
2.72%
|
7.86%
|
8.58%
|
6.48%
|
4.83%
|
-
|
Capitalization / Revenue
|
0.76
x
|
0.61
x
|
0.53
x
|
0.69
x
|
0.8
x
|
0.92
x
|
EV / Revenue
|
0.65
x
|
0.44
x
|
0.44
x
|
0.6
x
|
0.67
x
|
0.87
x
|
EV / EBITDA
|
11.9
x
|
5.68
x
|
4.07
x
|
10.5
x
|
7.24
x
|
8.39
x
|
EV / FCF
|
25.6
x
|
5.6
x
|
-119
x
|
-207
x
|
-84
x
|
14.4
x
|
FCF Yield
|
3.9%
|
17.9%
|
-0.84%
|
-0.48%
|
-1.19%
|
6.94%
|
Price to Book
|
0.72
x
|
0.59
x
|
0.52
x
|
0.67
x
|
0.86
x
|
1.88
x
|
Nbr of stocks (in thousands)
|
6,050
|
6,050
|
6,050
|
6,050
|
6,050
|
6,050
|
Reference price
2 |
147.2
|
127.2
|
116.6
|
154.4
|
207.0
|
292.2
|
Announcement Date
|
5/29/18
|
8/28/19
|
9/2/20
|
8/25/21
|
8/25/22
|
8/28/23
|
Fiscal Period: März |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
1,177
|
1,258
|
1,343
|
1,349
|
1,572
|
1,911
|
EBITDA
1 |
63.84
|
96.57
|
146.4
|
77.7
|
145.4
|
197.5
|
EBIT
1 |
52.43
|
83.47
|
132.7
|
62.84
|
124.5
|
178.3
|
Operating Margin
|
4.46%
|
6.64%
|
9.88%
|
4.66%
|
7.92%
|
9.33%
|
Earnings before Tax (EBT)
1 |
84.99
|
132.4
|
178.4
|
114
|
154.3
|
198.2
|
Net income
1 |
80.37
|
100.6
|
128.8
|
84.58
|
123.4
|
152.8
|
Net margin
|
6.83%
|
8%
|
9.59%
|
6.27%
|
7.85%
|
8%
|
EPS
2 |
13.29
|
16.63
|
21.29
|
13.98
|
20.40
|
25.26
|
Free Cash Flow
1 |
29.64
|
97.91
|
-5.027
|
-3.926
|
-12.53
|
115
|
FCF margin
|
2.52%
|
7.78%
|
-0.37%
|
-0.29%
|
-0.8%
|
6.01%
|
FCF Conversion (EBITDA)
|
46.42%
|
101.39%
|
-
|
-
|
-
|
58.2%
|
FCF Conversion (Net income)
|
36.87%
|
97.3%
|
-
|
-
|
-
|
75.22%
|
Dividend per Share
2 |
4.000
|
10.00
|
10.00
|
10.00
|
10.00
|
-
|
Announcement Date
|
5/29/18
|
8/28/19
|
9/2/20
|
8/25/21
|
8/25/22
|
8/28/23
|
Fiscal Period: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
131
|
221
|
110
|
122
|
200
|
110
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
29.6
|
97.9
|
-5.03
|
-3.93
|
-12.5
|
115
|
ROE (net income / shareholders' equity)
|
6.63%
|
7.91%
|
9.64%
|
6.15%
|
8.69%
|
12.8%
|
ROA (Net income/ Total Assets)
|
2.34%
|
3.54%
|
5.26%
|
2.41%
|
4.65%
|
7.81%
|
Assets
1 |
3,433
|
2,842
|
2,448
|
3,506
|
2,654
|
1,956
|
Book Value Per Share
2 |
205.0
|
216.0
|
225.0
|
229.0
|
240.0
|
155.0
|
Cash Flow per Share
2 |
4.370
|
2.500
|
2.630
|
12.70
|
22.60
|
7.860
|
Capex
1 |
50.3
|
13.7
|
49.7
|
35.2
|
1.87
|
22.5
|
Capex / Sales
|
4.27%
|
1.09%
|
3.7%
|
2.61%
|
0.12%
|
1.18%
|
Announcement Date
|
5/29/18
|
8/28/19
|
9/2/20
|
8/25/21
|
8/25/22
|
8/28/23
|
|
1st Jan change
|
Capi.
|
---|
| -7.63% | 28.94M | | +11.47% | 63.22B | | -3.47% | 46.34B | | +13.72% | 39.97B | | +17.83% | 25.46B | | +7.27% | 18.68B | | -0.57% | 17.24B | | -21.73% | 15.81B | | +0.22% | 14.9B | | -19.10% | 13.74B |
Other Specialty Chemicals
|